Risk of recurrence in high-risk T1 colon cancer following endoscopic and surgical resection: registry-based cohort study
BJS Open · 2024
DOI: 10.1093/bjsopen/zrae053 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift BJS Open, 2024. Verfasst von Emelie Nilsson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Division of Surgery, Skåne University Hospital, Lund University, Malmö, Sweden. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local, Registries, Colonic Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Crafoord Foundation, Lions Research Fund Skåne, Swedish research council.
Abstract (Originalsprache)
Background
Endoscopic resection of T1 colon cancer (CC) is currently limited by guidelines related to risk of lymph node metastases. However, clinical outcome following endoscopic and surgical resection is poorly investigated.
Method
A retrospective multicentre national cohort study was conducted on prospectively collected data from the Swedish colorectal cancer registry on all non-pedunculated T1 CC patients undergoing surgical and endoscopic resection between 2009 and 2021. Patients were categorized on the basis of deep submucosal invasion (Sm2–3), lymphovascular invasion (LVI), poor tumour differentiation, and R1/Rx into low- and high-risk cases. The primary outcomes of interest were recurrence rates and disease-free interval (DFI, defined as time from treatment to date of recurrence) according to resection methods and risk factors (sex, age at diagnosis, histologic grade, LVI, perineural invasion, mucinous subtype, submucosal invasion, tumour location, resection margin and nodal positivity in the surgical group).
Results
In total, 1805 patients undergoing endoscopic (488) and surgical (1317) resection with 60.0 months median follow-up were included. Recurrence occurred in 18 (3.7%) endoscopically and 48 (3.6%) surgically resected patients. Adjuvant treatment was administered in 7.4% and 0.2% of the cases respectively in the surgical and endoscopically treated patients. Five-year DFI was 95.6% after endoscopic and 96.2% after surgical resection, with no significant difference when adjusting for confounding factors (HR 1.03, 95% c.i. 0.56 to 1.91, P = 0.920). There were no statistically significant differences in recurrence comparing endoscopic (1.7%) versus surgical (3.6%) low-risk and endoscopic (5.4%) versus surgical (3.8%) high-risk cases. LVI was the only significant risk factor for recurrence in multivariate Cox regression (HR 3.73, 95% c.i. 1.76 to 7.92, P < 0.001).
Conclusions
This study shows no difference in recurrence after endoscopic and surgical resection in high-risk T1 CC. Although it was not possible to match groups according to treatment, the multivariate analysis showed that lymphovascular invasion was the only independent risk factor for recurrence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Clinical Sciences, Division of Surgery, Skåne University Hospital, Lund University, Malmö, Sweden.
ORCID-Profile: Erik Wetterholm, Carl-Fredrik Rönnow
Förderung
- The Crafoord Foundation
- Lions Research Fund Skåne
- Swedish research council
- Swedish cancer society
- Foundation for treatment of cancer at Malmö General Hospital
- Einar and Inga Nilsson foundation
Zitieren
APA
Nilsson, E., Wetterholm, E., Syk, I., Thorlacius, H., & Rönnow, C. F. (2024). Risk of recurrence in high-risk T1 colon cancer following endoscopic and surgical resection: registry-based cohort study. BJS Open. https://doi.org/10.1093/bjsopen/zrae053
Vancouver
Nilsson E, Wetterholm E, Syk I, Thorlacius H, Rönnow CF. Risk of recurrence in high-risk T1 colon cancer following endoscopic and surgical resection: registry-based cohort study. BJS Open. 2024. doi:10.1093/bjsopen/zrae053
BibTeX
@article{Nilsson2024,
author = {Nilsson, Emelie and Wetterholm, Erik and Syk, Ingvar and Thorlacius, Henrik and Rönnow, Carl-Fredrik},
title = {Risk of recurrence in high-risk T1 colon cancer following endoscopic and surgical resection: registry-based cohort study},
journal = {BJS Open},
year = {2024},
doi = {10.1093/bjsopen/zrae053}
}
EUVIMED